|
|
Volumn 51, Issue 1, 2010, Pages 12-15
|
|
Multifaceted perspective of the waiting list for liver transplantation: The value of pharmacokinetic models
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
SORAFENIB;
BIOLOGICAL MODEL;
BRAIN DISEASE;
CLINICAL EFFECTIVENESS;
CLINICAL TRIAL;
COMORBIDITY;
COST EFFECTIVENESS ANALYSIS;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG SAFETY;
EDITORIAL;
GRAFT SURVIVAL;
HEALTH CARE POLICY;
HEALTH ECONOMICS;
HOSPITAL ADMISSION;
HUMAN;
LIFE EXPECTANCY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER DISEASE;
LIVER FAILURE;
LIVER METABOLISM;
LIVER REGENERATION;
LIVER TRANSPLANTATION;
MORTALITY;
ORGAN DONOR;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESOURCE ALLOCATION;
SURVIVAL RATE;
SURVIVAL TIME;
TISSUE REPAIR;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
BENZENESULFONATES;
CARCINOMA, HEPATOCELLULAR;
COST-BENEFIT ANALYSIS;
HUMANS;
LIVER NEOPLASMS;
LIVER TRANSPLANTATION;
PYRIDINES;
TISSUE DONORS;
WAITING LISTS;
|
|
EID: 73449091161
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.23332 Document Type: Editorial |
|
Times cited : (30)
|
|
References (3)
|
